A Florida firm recently announced it replaced the nozzle on its OTC eye drops with one that prevents backflow without explaining that the change came after the Food and Drug Administration questioned the safety of its products while suggesting a recall may be necessary.
Nozzle At Tip Of Problems For Florida Eye Drop Firm: US FDA Warns Of GMP, Monograph Violations
Regenerative Processing replaces nozzle to prevent backflow for its Regener-Eyes drops but FDA warning states numerous questions about sterility at the firm’s plant and about its procedures and systems for preventing microbial contamination.
